GlassScriptPhysician profile
Gregory J Coffman
NPI 1982652962
$1,298.26
in general payments reported to CMS, 2019-2025
20 companies · $334 in 2025
The $334 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $44.26 · 2022: $79.68 · 2023: $397 · 2024: $312 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $171.86 | 2019-2025 | Bexsero, Pediarix, Menveo |
| Merck Sharp & Dohme LLC | $165.73 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $123.21 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $123.18 | 2024-2025 | |
| Depuy Synthes Sales INC. | $118.76 | 2023 | Matrixrib |
| Kaleo, INC. | $108.99 | 2019-2024 | Auvi-Q |
| Sanofi Pasteur INC. | $95.49 | 2023-2025 | |
| Cranial Technologies, INC | $79.92 | 2023-2025 | Doc Band |
| Alk-Abello, INC | $56.86 | 2025 | Neffy |
| Phadia US INC. | $52.43 | 2023-2025 | Immunocap |
| Abbott Laboratories | $30.08 | 2023 | |
| Springworks Therapeutics, INC. | $23.92 | 2025 | Gomekli |
| Verrica Pharmaceuticals INC. | $23.26 | 2024 | Ycanth |
| Aimmune Therapeutics, INC. | $22.82 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $21.43 | 2025 | Bylvay |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $20.56 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.43 | 2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $15.48 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.52 | 2019 | |
| Tris Pharma INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Coffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.